Published in Ann Surg on February 01, 2004
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14
Biologics in organ transplantation. Transpl Int (2012) 2.06
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64
Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50
Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44
Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26
Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol (2007) 1.23
Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23
Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19
Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17
Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12
Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08
CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03
Underutilization of pancreas donors. Transplantation (2003) 0.98
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98
Liver transplantation for HELLP syndrome. Liver Transpl (2005) 0.96
Nonhuman primate infections after organ transplantation. ILAR J (2008) 0.95
Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation (2009) 0.94
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93
Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation (2004) 0.93
Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology (2012) 0.91
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. Liver Transpl (2013) 0.88
Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation (2010) 0.87
Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation (2004) 0.87
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol (2010) 0.85
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85
Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Transplantation (2006) 0.84
Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation (2003) 0.84
Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant (2004) 0.83
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82
The Association Between Hospital Finances and Complications After Complex Abdominal Surgery: Deficiencies in the Current Health Care Reimbursement System and Implications for the Future. Ann Surg (2015) 0.82
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation (2002) 0.82
Urine proteomics in kidney transplantation. Transplant Rev (Orlando) (2013) 0.81
Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol (2003) 0.81
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol (2010) 0.80
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation (2003) 0.80
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79
Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation (2003) 0.79
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79
The role of B cells in solid organ transplantation. Semin Immunol (2011) 0.79
Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol (2011) 0.79
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl (2006) 0.78
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology (2015) 0.77
Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. Clin Transpl (2003) 0.77
Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Reply to Vanhove et al. Transpl Int (2013) 0.75
Cross-talk between T and B Cells in the Germinal Center following Transplantation. Transplantation (2016) 0.75
Liver transplantation for biliary atresia: 19-year, single-center experience. Exp Clin Transplant (2004) 0.75
The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. Ann Surg (2017) 0.75
Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. Transpl Immunol (2004) 0.75
Annual literature review for clinical transplants 2005. Clin Transpl (2005) 0.75
Incidental living donor nephrectomy: a unique expansion of the donor pool. Nephrol Dial Transplant (2005) 0.75
Liver transplantation 2007: where do we go from here? Curr Opin Organ Transplant (2007) 0.75
Cytokine kinetics profiling in pediatric renal transplant recipients. Pediatr Transplant (2010) 0.75
Starting well: induction immunosuppression after organ transplantation. Transpl Int (2013) 0.75